Putting the vulnerable first could end the pandemic faster
If high-income countries get vaccines first, it would avoid 33 per cent of preventable deaths, but equitable global distribution…
Author
The politics of pandemics
The COVID-19 pandemic is an opportunity to re-build better. At a global and national level, at a public health policy level as…
DPX-COVID-19 has potential to improve duration of immune response
Frederic Ors, CEO, IMV explains why the company believes that DPX-COVID-19 has the potential to improve the duration of the immune…
The back-to-AYUSH wave
The COVID-19 pandemic has seen increased interest in traditional remedies to build up personal immunity and nutrition. With…
Navigating a COVIDitised world
The pandemic has spurred governments to invest in healthcare systems and convinced companies that R&D budgets cannot be cut.…
Surfing the digital wave in pharma retail
The pharma retail space has had a digital component to it for quite a while, but the pandemic has served notice to the laggards in…
Agilent supports customer laboratories at every step: Sandeep Tandon
Sandeep Tandon, Sales Director, Services and Support Division & LSS India, Strategic Customer Programme, Agilent Technologies…
Our digital-funding-network will support India pharma’s next phase of super-growth
Ravi Tanniru, SVP Enterprise Sales, C2FO India explains C2FO’s concept to Viveka Roychowdhury, and why a high growth industry like…
HR and legal practices in the post-pandemic era
The COVID-19 pandemic has forced companies to re-look their strategies as they prepare for the new normal. One of the learnings is…
How the AMR Action Fund intends to support antibiotic-focused biotechs
While focus is on the global deaths from COVID-19 crossing the six lakh mark, we have lost seven lakh people to antimicrobial…
